Engineered Wnt7a ligands rescue blood–brain barrier and cognitive deficits in a COVID-19 mouse model
Brain · 2024
DOI: 10.1093/brain/awae031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Troy N Trevino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, COVID-19, Wnt Proteins, Disease Models, Animal. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, University of Illinois, NHLBI NIH HHS.
Abstract (Originalsprache)
Respiratory infection with SARS-CoV-2 causes systemic vascular inflammation and cognitive impairment. We sought to identify the underlying mechanisms mediating cerebrovascular dysfunction and inflammation following mild respiratory SARS-CoV-2 infection. To this end, we performed unbiased transcriptional analysis to identify brain endothelial cell signalling pathways dysregulated by mouse adapted SARS-CoV-2 MA10 in aged immunocompetent C57Bl/6 mice in vivo. This analysis revealed significant suppression of Wnt/β-catenin signalling, a critical regulator of blood–brain barrier (BBB) integrity. We therefore hypothesized that enhancing cerebrovascular Wnt/β-catenin activity would offer protection against BBB permeability, neuroinflammation, and neurological signs in acute infection. Indeed, we found that delivery of cerebrovascular-targeted, engineered Wnt7a ligands protected BBB integrity, reduced T-cell infiltration of the brain, and reduced microglial activation in SARS-CoV-2 infection. Importantly, this strategy also mitigated SARS-CoV-2 induced deficits in the novel object recognition assay for learning and memory and the pole descent task for bradykinesia. These observations suggest that enhancement of Wnt/β-catenin signalling or its downstream effectors could be potential interventional strategies for restoring cognitive health following viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA.
- Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA.
- Department of Microbiology and Immunology, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA.
- Laboratory of Neurovascular Signaling, Department of Molecular Biology, ULB Neuroscience Institute, Université libre de Bruxelles (ULB), Gosselies B-6041, Belgium.
ORCID-Profile: Troy N Trevino, Sarah E Lutz
Förderung
- NIGMS NIH HHS
- University of Illinois
- NHLBI NIH HHS
- DOD MS200290
- NIAID NIH HHS
Zitieren
APA
Trevino, T. N., Fogel, A. B., Otkiran, G., Niladhuri, S. B., Sanborn, M. A., Class, J., Almousawi, A. A., Vanhollebeke, B., Tai, L. M., Rehman, J., Richner, J. M., & Lutz, S. E. (2024). Engineered Wnt7a ligands rescue blood–brain barrier and cognitive deficits in a COVID-19 mouse model. Brain. https://doi.org/10.1093/brain/awae031
Vancouver
Trevino TN, Fogel AB, Otkiran G, Niladhuri SB, Sanborn MA, Class J, et al. Engineered Wnt7a ligands rescue blood–brain barrier and cognitive deficits in a COVID-19 mouse model. Brain. 2024. doi:10.1093/brain/awae031
BibTeX
@article{Trevino2024,
author = {Trevino, Troy N and Fogel, Avital B and Otkiran, Guliz and Niladhuri, Seshadri B and Sanborn, Mark A and Class, Jacob and Almousawi, Ali A and Vanhollebeke, Benoit and Tai, Leon M and Rehman, Jalees and Richner, Justin M and Lutz, Sarah E},
title = {Engineered Wnt7a ligands rescue blood–brain barrier and cognitive deficits in a COVID-19 mouse model},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae031}
}
EUVIMED